Tag: valine-citrulline linker
Remegen’s Disitamab Vedotin Attracts China’s largest-ever out-license Agreement at US $...
Earlier this month, Remegen Biosciences, a Shandong-based biotech company operating since 2008, scored the largest ever out-license deal for a Chinese biotech company when...
PepTalk 2017: Translating Toxicology Data from Non-human Species to the Clinical...
The need to improve the translation of risk between adverse events in non-human species and the clinical population was a topic addressed by several...
